During the past decade, Hospital General Universitario de Elda conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 5 clinical trials were completed, i.e. on average, 29.4% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 4 clinical trials were completed. i.e. 57.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital General Universitario de Elda" #1 sponsor was "Spanish Breast Cancer Research Group" with 6 trials, followed by "PETHEMA Foundation" with 4 trials sponsored, "Hospital Arnau de Vilanova" with 3 trials sponsored, "Spanish Lung Cancer Group" with 3 trials sponsored and "Elda University Hospital" with 3 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital General Universitario de Elda" #1 collaborator was "Bristol-Myers Squibb" with 2 trials as a collaborator, "Hoffmann-La Roche" with 2 trials as a collaborator, "Pfizer" with 2 trials as a collaborator, "Universidad Miguel Hernandez de Elche" with 2 trials as a collaborator and "Amgen" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Hospital General Universitario de Elda" are "Breast Cancer" (5 trials), "Carcinoma, Non-Small-Cell Lung" (2 trials), "Multiple Myeloma" (2 trials), "Acute Lymphoblastic Leukemia" (1 trials) and "Acute Promyelocytic Leukemia" (1 trials). Many other conditions were trialed in "Hospital General Universitario de Elda" in a lesser frequency.

Most popular intervention types in "Hospital General Universitario de Elda" are "Drug" (18 trials), "Procedure" (3 trials), "Behavioral" (2 trials), "Biological" (2 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Cyclophosphamide" (4 trials), "Epirubicin" (2 trials), "Fluorouracil" (2 trials), "Gemcitabine and Docetaxel" (2 trials) and "5-FU" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital General Universitario de Elda" are 28 trials for "All" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital General Universitario de Elda". undefined are not yet recruiting, 7 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Hospital General Universitario de Elda, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital General Universitario de Elda, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 4 trials that are defined as “Not Applicable".